Back
AIM ImmunoTech 10K Form
Sell
37
AIMI
AIM ImmunoTech
Last Price:
$0.09
Seasonality Move:
-3.71%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AIMI News And Ratings
See the #1 stock for the next 7 days that we like better than AIMI
AIMI Financial Statistics
Sales & Book Value
Annual Sales: | $170K |
---|---|
Cash Flow: | $-2.4M |
Price / Cash Flow: | 0 |
Annual Sales: | $-0.05 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -0.24000 |
---|---|
Net Income (TTM): | $-15.2M |
Gross Margin: | $139K |
Return on Equity: | -877.96% |
Return on Assets: | -126% |
AIM ImmunoTech Earnings Forecast
Key AIM ImmunoTech Financial Ratios
-
The Gross Profit Margin over the past 30 years for AIMI is 81.76%.
-
The Selling, General & Administrative Expenses for AIMI have been equal to 8,067.06% of Gross Profit Margin.
-
The Research & Development expenses have been 3,645.29% of Revenue.
-
The Net Earning history of AIMI is -10,188.24% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 18 years.
AIM ImmunoTech Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | OTCM |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | AIMI |
Website: | aimimmuno.com |
Debt
Debt-to-Equity Ratio: | -0.51 |
---|---|
Current Ratio: | 0.26 |
Quick Ratio: | 0.23 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
AIMI Technical Analysis vs Fundamental Analysis
Sell
37
AIM ImmunoTech (AIMI)
is a Sell
Is AIM ImmunoTech a Buy or a Sell?
-
AIM ImmunoTech stock is rated a SellThe current AIM ImmunoTech [AIMI] share price is $0.09. The Score for AIMI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.